CompletedNot applicableNCT05749653

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area

Studying Infectious disease with epilepsy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Universiteit Antwerpen
Principal Investigator: Bruno Mmbando, PhD
National Institute of Medical Research, Tanga
Intervention: Bi-annual CDTI(drug)
Enrollment: 6500 enrolled
Eligibility: All sexes
Timeline: 2017 – 2022

Study locations (1)

National Institute of Medical Research, Tanga, Tanzania

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05749653 on ClinicalTrials.gov

← Back to all trials